Summary: A precision functional genomics study has mapped when and how a major schizophrenia-associated gene acts in developing human brain cells. Researchers focused on ZNF804A, one of the earliest schizophrenia risk genes identified from human genomic studies, and found that its peak activity occurs during a critical early developmental window. The team used CRISPR-Cas9 gene editing in developing cortical neurons to reveal a direct link between local protein production and increased synaptic excitability—converting genetic risk into observable neuronal changes.
Using targeted CRISPR-Cas9 disruption of ZNF804A in developing human glutamatergic neurons, scientists discovered that loss of this gene’s normal function drives an abnormal increase in local protein synthesis at dendritic tips. That increase relocates ribosomes to distal dendrites and raises the levels of key synaptic proteins, producing hyper-excitable synaptic signaling when neurons are chemically stimulated. This work provides a concrete cellular mechanism that connects genetic risk for schizophrenia to altered neurobiology.
Key Facts
- Bridging genetics and neurobiology: Genome-wide studies have identified hundreds of schizophrenia-linked loci, but they rarely show when during development these genes act or which neuron types they affect. This study addresses that gap for ZNF804A.
- Developmental timing — second trimester: Functional genomic analysis shows that ZNF804A becomes highly active during early brain development, corresponding to the second trimester period of neurodevelopment.
- Cell-type specificity — glutamatergic neurons: ZNF804A expression and regulatory effects are concentrated in developing cortical glutamatergic neurons, allowing focused investigation of its cellular role.
- CRISPR interruption as a research tool: Researchers used CRISPR-Cas9 to reduce ZNF804A expression in human induced pluripotent stem cell–derived cortical neurons, enabling observation of downstream cellular consequences.
- Ribosome relocalization and local translation: Neurons lacking normal ZNF804A mobilized extra ribosomal machinery into dendrites, increasing local protein synthesis efficiency at synapses.
- Increased synaptic excitability: Elevated synaptic protein levels in ZNF804A-deficient neurons produced higher excitatory synapse density and greater electrical responsiveness upon stimulation.
Source: King’s College London
Researchers at King’s College London have defined the biological timing and neuronal consequences of altering a key schizophrenia-associated gene in developing human cortical neurons.
Schizophrenia is one of the most heritable psychiatric disorders and has a strong developmental component. Large-scale genomic studies have identified many genetic variants that raise the risk for schizophrenia, but translating those associations into clear cellular mechanisms has been a major challenge. Understanding when a risk gene is active and which cell types it affects is essential for linking genetics to disease biology and for identifying potential therapeutic targets.
This study, published in Science Advances by neuroscientists at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, narrows that gap for ZNF804A. The investigators mapped the gene’s activity to an early developmental window and pinpointed glutamatergic neurons as the primary affected cell type, then used CRISPR-Cas9 to disrupt ZNF804A and observe downstream effects on synapses and protein synthesis.
Professor Deepak Srivastava, Professor of Molecular Neuroscience at IoPPN and joint senior author, explained that genetic association alone does not reveal the timing or cellular context of gene action. Precision functional genomics was necessary to determine when ZNF804A is active and in which neuron subtype its regulation matters most.
Relatively little was previously known about ZNF804A’s role during neurodevelopment. The new experiments show that ZNF804A regulates two linked cellular processes: synaptogenesis (formation of excitatory synapses) and subcellular protein production. By impairing the gene in developing glutamatergic neurons, researchers observed increased excitatory synapse density and enhanced local protein translation within dendrites.
High-content confocal imaging demonstrated more synaptic proteins at neuronal junctions in ZNF804A-impaired neurons, and chemical stimulation produced larger electrical responses compared with control neurons. Proteomic analysis of neuronal compartments revealed elevated ribosomal and translational proteins within neurites, matching the imaging data for increased local synthesis.
Neurons rely on location-specific protein production to tune synaptic strength. Ribosomes transported into distal dendrites allow rapid synthesis of proteins right at synaptic sites. When ZNF804A is disrupted, this local translational control loosens, producing more protein at dendritic tips and increasing synaptic excitability—an effect that could perturb circuit development.
Professor Anthony Vernon, joint senior author, emphasized that these targeted genetic manipulations do not recreate the full genetic landscape of schizophrenia. Instead, they reveal what a single risk gene controls at a specific developmental stage and cell type. Scaling this approach to other risk genes will help determine whether diverse genetic risks converge on shared pathways, such as dysregulated local translation and synaptogenesis.
Funding: This research received support from the UK Medical Research Council (MRC Centre for Neurodevelopmental Disorders, MRC Doctoral Training Partnership), the Royal Society UK, the Brain and Behavior Foundation, and the National Centre for the Replacement, Refinement and Reduction of Animals in Research.
Key Questions Answered:
A: Schizophrenia risk involves many genetic loci, but understanding the mechanism of even one well-established risk gene gives researchers a model for how genetic variation can change neuronal development. ZNF804A was one of the first robustly associated genes, and mapping its timing, cell-type specificity, and cellular effects provides a blueprint for connecting other risk genes to shared biological pathways.
A: Dendrites are where neurons form many of their synaptic connections. Local protein synthesis at dendritic tips determines which receptors and scaffolding proteins are available at each synapse. Excess ribosomes and uncontrolled local translation increase synaptic protein density, which can raise excitatory synapse formation and electrical responsiveness—disturbing the balance of neural signaling.
A: No. In this study, CRISPR-Cas9 was used as an experimental tool to disrupt a gene and observe the consequences, not as a therapy. Since ZNF804A acts during fetal brain development, its critical role occurs long before adult life. However, identifying the downstream hyperactive protein-translation mechanism provides a clear target for drug development that could modulate hyper-excitable pathways.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by staff.
About this schizophrenia and genetics research news
Author: Franca Davenport
Source: King’s College London
Contact: Franca Davenport – King’s College London
Image: The image is credited to Neuroscience News
Original Research: Open access. “Schizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons” by Laura Sichlinger et al., published in Science Advances. DOI: 10.1126/sciadv.aea0755
Abstract
Schizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons
ZNF804A was among the first genes robustly associated with schizophrenia from large-scale genomic studies. Prior work has linked ZNF804A to regulation of gene expression and synaptic function, but its role in neurodevelopment and schizophrenia pathogenesis remained unclear. To probe its developmental function, researchers made isogenic human induced pluripotent stem cells with reduced ZNF804A expression, differentiated them into developing cortical glutamatergic neurons, and analyzed transcriptomic, synaptic, and proteomic changes.
Mutant neurons showed modest transcriptomic changes, but high-content confocal imaging revealed increased excitatory synapse density. Compartment-specific proteomics detected elevated ribosomal and translational proteins within neurites, and imaging confirmed enhanced local protein synthesis. Together, these results indicate that in developing human cortical glutamatergic neurons, ZNF804A helps regulate excitatory synapse formation by controlling local protein translation.